DULCOLAX SUPPOSITORY

국가: 캐나다

언어: 영어

출처: Health Canada

유효 성분:

BISACODYL

제공처:

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

ATC 코드:

A06AB02

INN (국제 이름):

BISACODYL

복용량:

5MG

약제 형태:

SUPPOSITORY

구성:

BISACODYL 5MG

관리 경로:

RECTAL

패키지 단위:

3

처방전 유형:

OTC

치료 영역:

CATHARTICS AND LAXATIVES

제품 요약:

Active ingredient group (AIG) number: 0101506001; AHFS:

승인 상태:

CANCELLED POST MARKET

승인 날짜:

2013-12-05

제품 특성 요약

_Dulcolax Prescribing Information _
PRESCRIBING INFORMATION
DULCOLAX
®
Bisacodyl
Tablets 5 mg
Suppositories 5 mg (children) and 10 mg (adult)
Boehringer Ingelheim Std.
Stimulant Laxative
Boehringer Ingelheim Canada Ltd.
5180 South Service Rd.
Burlington, ON L7L 5H4
CCDS: 0074-06
Date of Revision:
August 16, 2013
Submission Control No:
142262, 142263, 142264
_Dulcolax Prescribing Information _
TABLE OF CONTENTS
[To update, right-click anywhere in the Table of Contents and select
“Update Field”, “Update
entire table”, click OK.]
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................5
DRUG INTERACTIONS
....................................................................................................5
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................6
STORAGE AND STABILITY
............................................................................................7
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................7
PART III: CONSUMER
INFORMATION................................................................................8
_ _
_Dulcolax Prescribing Information Page 3 of 11_
DULCOLAX
®
Bisacodyl
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FOR